Get the Stockscreener App
2.23
6.19%
0.13
After Hours:
2.20
-0.03
-1.35%
Mangoceuticals Inc stock is traded at $2.23, with a volume of 92,526.
It is up +6.19% in the last 24 hours and up +32.74% over the past month.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
See More
Previous Close:
$2.10
Open:
$2.07
24h Volume:
92,526
Relative Volume:
0.33
Market Cap:
$24.60M
Revenue:
$755.00K
Net Income/Loss:
$-9.33M
P/E Ratio:
-0.3905
EPS:
-5.71
Net Cash Flow:
$-5.43M
1W Performance:
+5.69%
1M Performance:
+32.74%
6M Performance:
-11.86%
1Y Performance:
-59.93%
1-Day Range:
$2.0288
$2.28
1-Week Range:
$2.0288
$2.475
52-Week Range:
$1.32
$7.659
Mangoceuticals Inc Stock (MGRX) Company Profile
Name
Mangoceuticals Inc
Sector
Industry
Phone
(833) 626-4679
Address
15110 DALLAS PKWY, SUITE 600, DALLAS
Compare MGRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
2.23 | 23.28M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
283.57 | 38.32B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
62.78 | 9.21B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
113.06 | 8.79B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
54.57 | 9.70B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
39.61 | 6.65B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Stock (MGRX) Latest News
Mangoceuticals, Inc. (NASDAQ: MGRX) is a Stock Spotlight on 3/24 - The Globe and Mail
Mangoceuticals Amends Promissory Note with Indigo Capital - TipRanks
Mangoceuticals shares results from field studies on MGX-0024 - Yahoo Finance
Mangoceuticals (NASDAQ:MGRX) Shares Up 11.8% – Should You Buy? - Defense World
Mangoceuticals reports promising antiviral for poultry health By Investing.com - Investing.com Nigeria
Mangoceuticals reports promising antiviral for poultry health - Investing.com
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory - GlobeNewswire
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu - The Globe and Mail
Mangoceuticals, Inc. Terminates Agreements with Key Partners - TipRanks
MANGOCEUTICALS, INC. SEC 10-Q Report - TradingView
Erectile Dysfunction Treatment Market Generated - openPR.com
Tim Corkum on Mangoceuticals Inc. (NASDAQ: MGRX) Breaking into the High-Growth Oral Pouch Market with a Smokeless Tech Acquisition - InvestorNews
Mangoceuticals Settles Lawsuit with Stock Issuance - TipRanks
Geode Capital Management LLC Reduces Stock Holdings in Mangoceuticals, Inc. (NASDAQ:MGRX) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Mangoceuticals Inc’s latest rating changes from various analysts - knoxdaily.com
MGRX’s Market Ups and Downs: What’s Behind the 2023 Stock Performance? - investchronicle.com
Mangoceuticals Emerges as a Leader Amid Rapid Expansion of Oral Stimulant Pouch Market - InvestorNews
ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market - InvestorNews
CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Gr - TradingView
Mangoceuticals acquires Smokeless Tech intellectual property - Investing.com
Mangoceuticals enters into agreement to acquire assets of Smokeless Technology - TipRanks
Mangoceuticals Acquires IP to Expand Product Line - TipRanks
Mangoceuticals acquires Smokeless Tech intellectual property By Investing.com - Investing.com South Africa
ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector - Newsfile
Mangoceuticals to Acquire Smokeless Technology's Intellectual Property - marketscreener.com
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division - The Manila Times
Mangoceuticals Announces Strategic Entry into High Growth - GlobeNewswire
MangoRx Targets $37B Pouch Industry: Acquires Smokeless Tech IP, Lands Former JUUL President - Stock Titan
Mangoceuticals Is Reengineering the Self-Care Blueprint with Better Personal Health and Wellness Solutions - Yahoo Finance
MGRX’s Market Quandary: Decoding the Ups and Downs of 2023 - investchronicle.com
Trading Day Review: Mangoceuticals Inc (MGRX) Loses Momentum, Closing at 2.04 - DWinneX
What to expect from Mangoceuticals Inc’s (MGRX) current quarter earnings? - uspostnews.com
Can Mangoceuticals Inc (NASDAQ: MGRX) Still Be Hot This Week? - Stocksregister
Stock market nears its worst April in 93 years - The Globe and Mail
CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape - Corsicana Daily Sun
Mangoceuticals Disrupts $33B Health Market: 5 Revolutionary Products Including FDA-Approved Treatments - Stock Titan
Mangoceuticals Issues Bonus Shares to Leadership - MSN
Mangoceuticals (NASDAQ:MGRX) Trading Down 10.3% – Time to Sell? - Defense World
MGRX stock touches 52-week low at $1.79 amid market challenges By Investing.com - Investing.com South Africa
MGRX stock touches 52-week low at $1.79 amid market challenges - Investing.com Canada
Why FedEx (FDX) Stock Is Nosediving - The Globe and Mail
Mangoceuticals issues new shares from preferred stock conversion - Investing.com India
Mangoceuticals issues new shares from preferred stock conversion By Investing.com - Investing.com South Africa
Mangoceuticals Inc (MGRX) Stock: Analyzing the Market Value - News Heater
Mangoceuticals Issues Common Stock in Exchange for Preferred - Investing.com Australia
Mangoceuticals Issues Common Stock in Exchange for Preferred By Investing.com - Investing.com India
Mangoceuticals stock hits 52-week low at $2.06 - Investing.com India
Mangoceuticals Inc Stock (MGRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.62%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):